Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study
AATD remains underdiagnosed in pre-LT assessments and is poorly understood amongst practitioners in France. Improved screening can enhance patient management, especially with emerging potentially curative treatments.
Authors
- Philippe Ichai
- Térésa Antonini (ORCID: https://orcid.org/0009-0005-0441-4547)
- Laure Elkrief (ORCID: https://orcid.org/0000-0003-2843-1710)
- Isaac Ruiz (ORCID: https://orcid.org/0000-0002-3711-1287)
- Mylène Sebagh (ORCID: https://orcid.org/0000-0002-6122-2542)
- Rodolphe Anty (ORCID: https://orcid.org/0000-0001-8194-9805)
- Daniel Cherqui (ORCID: https://orcid.org/0000-0001-5270-2731)
- Manon Evain (ORCID: https://orcid.org/0000-0002-9409-2887)
- Guillaume Lassailly (ORCID: https://orcid.org/0000-0002-6955-244X)
- Ilias Kounis (ORCID: https://orcid.org/0000-0003-3876-2097)
- Didier Samuel
- Audrey Coilly
- Pauline Houssel Debry
- Alessandra Mazzola
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Sorbonne Université (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Hospices Civils de Lyon (FR)
- Pitié-Salpêtrière Hospital (FR)
- Centre Hospitalier de l’Université de Montréal (CA)
- Centre Hospitalier Universitaire de Rennes (FR)
- Hôpital Paul-Brousse (FR)
- European Genomic Institute for Diabetes (FR)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1111/apt.70183
- Citations
- 2
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.64